Journal of Medicinal Chemistry · 2017 · 45 citations · 18 references
MedicineMolecular BiologyOncologyMolecular OncologyOncogenesTranscriptional RegulationG-quadruplex ChemistryLigand BindingMyc Family OncogenesPromoter RegulationTranscription Factor OncogenesAnticancer ActivityC-myc RegulationG-quadruplex Promoter RegulationG-quadruplex StructureMyc OncogenesMyc Proto-oncogeneMyc Transcriptional RepressionTherapeutic Targeting Of Myc
Transcriptional control of c-myc oncogene is an important strategy for antitumor drug design. G-quadruplexes in the promoter region have been proven to be the transcriptional down-regulator of this gene. The transcriptional factor NM23-H2 can reactivate c-myc transcription by unwinding the G-quadruplex structure. Thus, down-regulation of c-myc transcription via disrupting G-quadruplex-NM23-H2 interaction might be a potential approach for cancer therapy. Here, a series of new isaindigotone derivatives were designed and synthesized based on our previous study. The abilities of these derivatives on interacting with G-quadruplexes or NM23-H2, and disrupting G-quadruplex-NM23-H2 interaction were evaluated. Among these derivatives, 19d and 22d showed remarkable abilities on disrupting G-quadruplex-NM23-H2 interaction. They exhibited significant effects on c-myc-relating processes in SiHa cells, including inhibiting the transcription and translation, inhibiting cellular proliferation, inducing apoptosis, and regulating cell cycle. Our findings provided the basis for the anticancer strategy based on c-myc transcriptional regulation via small molecules disrupting G-quadruplex-protein interaction.
18
Quantitative visualization of DNA G-quadruplex structures in human cells
Giulia Biffi, David Tannahill, John McCafferty et al. · Nature Chemistry · 2013 · 2.2K citations
Protein-binding assays in biological liquids using microscale thermophoresis
Christoph J. Wienken, Philipp Baaske, Ulrich Rothbauer et al. · Nature Communications · 2010 · 1.1K citations · Full text
Expression of Cellular Oncogenes in Human Malignancies
Dennis J. Slamon, Jean B. deKernion, Inder M. Verma et al. · Science · 1984 · 833 citations
Medicine, Cancer Biology, Oncology +13